TINA ENGLAND: Open Payments
NPI 1760728679 · FLATWOODS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 58 payments from 11 companies in 2025. Trend: 2023 $621 · 2024 $804 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $158 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Novo Nordisk Inc | 6 | $136 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Lilly USA, LLC | 4 | $64 |
| Corcept Therapeutics | 3 | $52 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, AIRSUPRA, REXULTI, QULIPTA, Rybelsus, Ozempic, MOUNJARO.
Industry payments across KY — which companies pay providers there.
